277 related articles for article (PubMed ID: 25474713)
1. Predictors of clinical use of pleurodesis and/or indwelling pleural catheter therapy for malignant pleural effusion.
Fysh ETH; Bielsa S; Budgeon CA; Read CA; Porcel JM; Maskell NA; Lee YCG
Chest; 2015 Jun; 147(6):1629-1634. PubMed ID: 25474713
[TBL] [Abstract][Full Text] [Related]
2. Comments on predictors of clinical use of pleurodesis and/or indwelling pleural catheter therapy for malignant pleural effusion.
Boshuizen RC; Burgers JA; van den Heuvel MM
Chest; 2015 Jun; 147(6):e232. PubMed ID: 26033142
[No Abstract] [Full Text] [Related]
3. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14).
Boshuizen RC; Vd Noort V; Burgers JA; Herder GJM; Hashemi SMS; Hiltermann TJN; Kunst PW; Stigt JA; van den Heuvel MM
Lung Cancer; 2017 Jun; 108():9-14. PubMed ID: 28625655
[TBL] [Abstract][Full Text] [Related]
4. OPTIMUM: a protocol for a multicentre randomised controlled trial comparing Out Patient Talc slurry via Indwelling pleural catheter for Malignant pleural effusion vs Usual inpatient Management.
Sivakumar P; Douiri A; West A; Rao D; Warwick G; Chen T; Ahmed L
BMJ Open; 2016 Oct; 6(10):e012795. PubMed ID: 27798020
[TBL] [Abstract][Full Text] [Related]
5. Indwelling Pleural Catheter versus Pleurodesis for Malignant Pleural Effusions. A Systematic Review and Meta-Analysis.
Iyer NP; Reddy CB; Wahidi MM; Lewis SZ; Diekemper RL; Feller-Kopman D; Gould MK; Balekian AA
Ann Am Thorac Soc; 2019 Jan; 16(1):124-131. PubMed ID: 30272486
[TBL] [Abstract][Full Text] [Related]
6. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion.
Fysh ETH; Waterer GW; Kendall PA; Bremner PR; Dina S; Geelhoed E; McCarney K; Morey S; Millward M; Musk AWB; Lee YCG
Chest; 2012 Aug; 142(2):394-400. PubMed ID: 22406960
[TBL] [Abstract][Full Text] [Related]
7. Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion: a meta-analysis.
Yeung M; Loh EW; Tiong TY; Tam KW
Clin Exp Metastasis; 2020 Aug; 37(4):541-549. PubMed ID: 32524317
[TBL] [Abstract][Full Text] [Related]
8. Interventional therapies for malignant pleural effusions: the present and the future.
Thomas R; Francis R; Davies HE; Lee YC
Respirology; 2014 Aug; 19(6):809-22. PubMed ID: 24947955
[TBL] [Abstract][Full Text] [Related]
9. Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: a multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters.
Azzopardi M; Thomas R; Muruganandan S; Lam DC; Garske LA; Kwan BC; Rashid Ali MR; Nguyen PT; Yap E; Horwood FC; Ritchie AJ; Bint M; Tobin CL; Shrestha R; Piccolo F; De Chaneet CC; Creaney J; Newton RU; Hendrie D; Murray K; Read CA; Feller-Kopman D; Maskell NA; Lee YC
BMJ Open; 2016 Jul; 6(7):e011480. PubMed ID: 27381209
[TBL] [Abstract][Full Text] [Related]
10. Home-management of malignant pleural effusion with an indwelling pleural catheter: ten years experience.
Bertolaccini L; Viti A; Gorla A; Terzi A
Eur J Surg Oncol; 2012 Dec; 38(12):1161-4. PubMed ID: 22959168
[TBL] [Abstract][Full Text] [Related]
11. Predictors of talc pleurodesis outcome in patients with malignant pleural effusions.
Yildirim H; Metintas M; Ak G; Metintas S; Erginel S
Lung Cancer; 2008 Oct; 62(1):139-44. PubMed ID: 18403045
[TBL] [Abstract][Full Text] [Related]
12. Thoracic Ultrasound as an Early Predictor of Pleurodesis Success in Malignant Pleural Effusion.
Corcoran JP; Hallifax RJ; Mercer RM; Yousuf A; Asciak R; Hassan M; Piotrowska HE; Psallidas I; Rahman NM
Chest; 2018 Nov; 154(5):1115-1120. PubMed ID: 30243566
[TBL] [Abstract][Full Text] [Related]
13. Indwelling pleural catheters for malignancy-associated pleural effusion: report on a single centre's ten years of experience.
Frost N; Brünger M; Ruwwe-Glösenkamp C; Raspe M; Tessmer A; Temmesfeld-Wollbrück B; Schürmann D; Suttorp N; Witzenrath M
BMC Pulm Med; 2019 Dec; 19(1):232. PubMed ID: 31791305
[TBL] [Abstract][Full Text] [Related]
14. Phenotyping malignant pleural effusions.
Lui MM; Fitzgerald DB; Lee YC
Curr Opin Pulm Med; 2016 Jul; 22(4):350-5. PubMed ID: 27055073
[TBL] [Abstract][Full Text] [Related]
15. Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma.
Crnjac A; Sok M; Kamenik M
Eur J Cardiothorac Surg; 2004 Aug; 26(2):432-6. PubMed ID: 15296910
[TBL] [Abstract][Full Text] [Related]
16. Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline.
Feller-Kopman DJ; Reddy CB; DeCamp MM; Diekemper RL; Gould MK; Henry T; Iyer NP; Lee YCG; Lewis SZ; Maskell NA; Rahman NM; Sterman DH; Wahidi MM; Balekian AA
Am J Respir Crit Care Med; 2018 Oct; 198(7):839-849. PubMed ID: 30272503
[TBL] [Abstract][Full Text] [Related]
17. Pleural controversy: pleurodesis versus indwelling pleural catheters for malignant effusions.
MacEachern P; Tremblay A
Respirology; 2011 Jul; 16(5):747-54. PubMed ID: 21545373
[TBL] [Abstract][Full Text] [Related]
18. The significance of thoracoscopic mechanical pleurodesis for the treatment of malignant pleural effusions.
Crnjac A
Wien Klin Wochenschr; 2004; 116 Suppl 2():28-32. PubMed ID: 15506307
[TBL] [Abstract][Full Text] [Related]
19. Increased pleural fluid adenosine deaminase levels in patients with malignant pleural effusions: a potential predictor of talc pleurodesis outcome.
Yildirim H; Metintas M; Ak G; Erginel S; Alatas F; Kurt E; Metintas S; Ucgun I
Lung; 2007 Dec; 185(6):349-54. PubMed ID: 17952507
[TBL] [Abstract][Full Text] [Related]
20. Thoracoscopic collagen pleurodesis in the treatment of malignant pleural effusions.
Akopov AL; Egorov VI; Varlamov VV; Levashev YN; Artioukh DY
Eur J Cardiothorac Surg; 2005 Nov; 28(5):750-3. PubMed ID: 16198593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
